Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery
Clinical trial NCT03939923 · COMPLETED
Trial details
- NCT number
- NCT03939923
- Sponsor
- West Virginia University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2021-07-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.